MiMedx Group Inc (MDXG) stock news · rev $418.6M
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
This MDXG news page leads with what MiMedx Group Inc filed — not a scraped headline mill.
No cached 8-K sentence for MDXG yet. We will not pad this page with generic market recap.
Latest reported MDXG revenue for 2025-12-31 was $418.6M. Net income was $48.6M. Revenue was up 20.0% from 2024-12-31 to 2025-12-31. MDXG currently screens at market cap $537.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MDXG stock page; for the tape open the quote page.
MDXG stock news FAQ
What are MDXG's latest revenue and net income?
Latest cached MiMedx Group Inc (MDXG) revenue for Dec 31, 2025 was $418.6M. Net income was $48.6M. Statements: https://lician.com/financials/mdxg
How did MDXG revenue change from the prior cached period?
Cached MiMedx Group Inc (MDXG) revenue was up 20.0% from $348.9M (Dec 31, 2024) to $418.6M (Dec 31, 2025). Statements: https://lician.com/financials/mdxg
What is MDXG's market cap?
MiMedx Group Inc (MDXG) market cap is $537.7M on the latest cached fundamentals snapshot.
What kind of company is MDXG?
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
Where is MDXG stock news listed?
Cached stock news for MiMedx Group Inc (MDXG) is listed at https://lician.com/news/mdxg. Filings: https://lician.com/sec/mdxg
Not investment advice.